Henan Cancer Hospital: Lung Neoplasms trials

The registry lists 17 Lung Neoplasms studies with Henan Cancer Hospital as lead sponsor. 8 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 1Phase 2 10Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Cohort Study on the Prevention of Nausea and Vomiting Induced by Concurrent Chemoradiotherapy for Lung Cancer Using Rolapitant and PalonosetronNot yet recruitingNCT07442890Not applicable
• Clinical Study of Trop2 CAR-NK in the Treatment of Relapsed/Refractory Non-Small Cell Lung Cancer (NSCLC)Not yet recruitingNCT06454890Phase 1/2
• An Exploratory Study of Efficacy and Safety of Iruplinalkib Tablets in Patients With ROS1 Positive Non-small Cell Lung CancerRecruitingNCT06436885Early Phase 1
• A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung CancerRecruitingNCT06406673Phase 2
• Patient-derived Organoid Drug Sensitivity Guided Treatment for Recurrent Small Cell Lung CancerRecruitingNCT06406660Not applicable
• Patient-derived Organoid Drug Sensitivity Guided Treatment for Drug-resistant Recurrent Non-Small Cell Lung CancerRecruitingNCT06406608Not applicable
• Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung CancerNot yet recruitingNCT05647330Phase 2
• AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung CancerRecruitingNCT05377658Phase 2
• Utidelone in Third-line and Above Treatment of Small Cell Lung CancerStatus unknownNCT05299255Phase 2
• An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLCStatus unknownNCT05252091Phase 2
• Low-dose Gemcitabine Combined With Nivolumab for Second-line and Above Line Treatment of NSCLCStatus unknownNCT04331626Phase 4
• Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLCCompletedNCT04055792Phase 2
• Study of CT and MR in the Lung CancerStatus unknownNCT04034667
• Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung CancerStatus unknownNCT03983759Phase 2
• SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung CancerStatus unknownNCT03755115Phase 2
• Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung CancerStatus unknownNCT03389087Phase 2
• Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal CancerWithdrawnNCT03110939Not applicable